Stay updated on Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page
- Check6 days agoChange DetectedRevision label in the page footer updated from v3.6.2 to v3.6.3, indicating a new version of the page/component.SummaryDifference0.0%

- Check13 days agoChange DetectedThe page shows Revision: v3.6.2 now replaces the previous Revision: v3.6.0 in the footer metadata. This reflects a small site maintenance update that does not alter the study information.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now indicates that recruitment is closed and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study). A revision tag updated to v3.6.0 accompanies a minor formatting change to the Intervention/Treatment label.SummaryDifference0.4%

- Check34 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a minor site maintenance update. It does not modify the displayed trial details or user-facing features.SummaryDifference0.0%

- Check56 days agoChange DetectedA new publication citation was added to the Publications section (Gadgeel et al., 2024), updating the study’s references. The page revision is noted as v3.5.4.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page revision label was updated from **v3.5.2** to **v3.5.3**, indicating a minor technical version update without altering the displayed study information.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page.